Blood Targets of Adjuvant Drugs Against COVID19

While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-k...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Blood Med
Glavni autori: Di Micco, Pierpaolo, Di Micco, Gianluca, Russo, Vincenzo, Poggiano, Maria Rita, Salzano, Ciro, Bosevski, Marijan, Imparato, Michele, Fontanella, Luca, Fontanella, Andrea
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Expert Opinion
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7338832/
https://ncbi.nlm.nih.gov/pubmed/32694923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S256121
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items